Mark Cuban Cost Plus Drug Company
PrivateLast Round
Seed
Jan 25, 2019
Total Funding Raised
$1.45M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Mark Cuban Cost Plus Drug Company is a public-benefit corporation that operates an online pharmacy and wholesale marketplace providing generic medications at transparent, low prices by bypassing traditional pharmacy benefit managers.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, E-commerce, D2C Brands
Business Model
B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mark Cuban Cost Plus Drug Company Comparables
Compare Mark Cuban Cost Plus Drug Company with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Honeybee Health | 88% | |
| DiRx | 86% | |
| ScriptCo Pharmacy | 83% |
Mark Cuban Cost Plus Drug Company Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Mark Cuban Cost Plus Drug Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maveron | Accelerator, Seed |
| Asymmetry Ventures | Accelerator, Seed |
| Y Combinator | Seed, Accelerator |
| Lombardstreet Ventures | Accelerator, Seed |
| C3 Ventures | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Open roles increased to 27, representing 19% of headcount.
- Sep 28, 2026
Open roles increased to 20, double the trailing average.
Recent news
Latest coverage and updates
- partners_withOct 15, 2026
Mark Cuban Cost Plus Drug Company partners with Epic Systems Corporation to build Prescription Marketplace, which lets clinicians and patients compare insurance-covered and cash-pay prescription prices across pharmacies before ordering medication.
Mark Cuban Cost Plus Drug Company Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mark Cuban Cost Plus Drug Company's valuation, stock price, and market status.
Is Mark Cuban Cost Plus Drug Company a public or private company?
Mark Cuban Cost Plus Drug Company is a private company.
What is the current stock price of Mark Cuban Cost Plus Drug Company?
Mark Cuban Cost Plus Drug Company is a private company, so its shares have no public market price. Caplight tracks Mark Cuban Cost Plus Drug Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mark Cuban Cost Plus Drug Company worth (valuation)?
Valuation information for Mark Cuban Cost Plus Drug Company is not publicly available.
Can I buy Mark Cuban Cost Plus Drug Company stock?
Mark Cuban Cost Plus Drug Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mark Cuban Cost Plus Drug Company's last funding round?
Mark Cuban Cost Plus Drug Company's most recent funding round was Seed on January 25, 2019.
Who are the main investors in Mark Cuban Cost Plus Drug Company?
Key investors in Mark Cuban Cost Plus Drug Company include Y Combinator.
Will Mark Cuban Cost Plus Drug Company IPO soon?
No public IPO plans have been announced for Mark Cuban Cost Plus Drug Company.
How can I track Mark Cuban Cost Plus Drug Company secondary market activity?
Caplight tracks bids, offers, and trades in Mark Cuban Cost Plus Drug Company's shares on secondary markets.